This clinical trial evaluates the acceptability and effectiveness of an educational intervention (Lung Toolkit) for improving knowledge about lung cancer and lung cancer screening among American Indian/Alaskan Native (AI/AN) cigarette smokers. The Lung Toolkit is an educational intervention, including a website and a physical artifact pouch, specifically tailored to the needs of AI/AN individuals. The website includes evidence-based resources about lung health and lung cancer screening, facts about commercial tobacco and traditional tobacco, national and local smoking cessation and screening resources, and community-building resources such as stories from AI/AN community members about their experiences with lung cancer screening and smoking cessation. The physical artifact pouch links to the website with a quick response code and contains ceremonial herbs and motivational messaging around smoking cessation and lung cancer screening. The Lung Toolkit intervention may be effective for improving knowledge about lung cancer and lung cancer screening among AI/AN cigarette smokers.
Between ages 50-80
Self-identify as AI/AN
Self-reported 10 pack-year smoking history (commercial tobacco i.e. cigarettes)
Ability to understand and willingness to sign an informed consent document
Not between ages 50-80
Having less than a 10 pack-year history of smoking commercial tobacco
Inability to communicate in written and verbal English
Having any cognitive impairment that compromises the ability to provide informed consent
Single group
Educational Intervention
Other interventionReceive Lung Toolkit materials
Educational Intervention
Other interventionReceive guided review of Lung Toolkit materials
Interview
Other interventionAncillary studies
Questionnaire Administration
Other interventionAncillary studies
Acceptability of intervention
Acceptability will be evaluated using the Acceptability of Intervention (AIM) assessment score and semi-structured interviews. AIM results will be summarized and presented as a range of score from 1 to 5.
Lung cancer screening knowledge
Will be evaluated using a validated measure for assessing lung cancer screening knowledge (Lung Cancer Screening Knowledge Score \[LKS\]-7). Pre- and post-intervention LKS responses will be compared via Cochran-Mantel-Haenszel and Friedman tests.
User engagement
The effectiveness of the website in terms of engagement will be measured by tracking of bounce rate (percentage of visitors who land on website homepage and leave immediately without taking any further action, or viewing other pages).
User behavior
Participant behavior, and how participants navigate the website will be measured through click tracking (tracking of where users click on a website).
Medical mistrust
The intervention efficacy potential to mitigate medical mistrust will be evaluated using validated measures of discrimination and medical mistrust (Discrimination in Medical Settings; Group-Based Medical Mistrust Scale). Participant responses for each scale will be summarized with the median and range of scores at pre- and post-intervention.
Perceived smoking-related stigma
The intervention efficacy potential to reduce perceived smoking-related stigma will be evaluated using a validated measure of perceived smoking-related stigma (Cataldo Lung Cancer Stigma Scale, smoking-related subscale). Participant responses for each scale will be summarized with the median and range of scores at pre- and post-intervention.
Click on the lead sponsor to view all of their trials.
Fred Hutchinson Cancer Center
Lead sponsor
Bristol-Myers Squibb
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
